Sixth International Conference on Ethical Issues in Biomedical Engineering to Be Held in Brooklyn April 1 – 3
Mar 17, 2011
Sixth International Conference on Ethical Issues in Biomedical Engineering to Be Held in Brooklyn April 1 – 3
SUNY Downstate Health Sciences University, Polytechnic Institute of New York University, and The New York Academy of Sciences will hold the Sixth International Conference on Ethical Issues in Biomedical Engineering April 1 – 3. The reception and registration will take place April 1 at the New York Marriott at the Brooklyn Bridge, 333 Adams Street, Brooklyn 11201. Lectures and panel discussions will be held April 2 – 3 at Pfizer Auditorium, Polytechnic Institute of NYU, 5 MetroTech Center, Brooklyn, 11201.
The conference will examine the ethical issues associated with the development of new implants, devices, and treatments to improve the quality of life of patients with devastating diseases. Biomedical engineers, philosophers, research scientists, lawyers, students, clinicians, and representatives from industry and government will explore ethical guidelines to address developments in biomedical engineering.
The gathering of speakers, presenters, and moderators from around the globe will include John C. LaRosa, MD, president of SUNY Downstate, who will give introductory remarks, as will Ellis Rubenstein, PhD, president of the New York Academy of Sciences, and Gene R. DiResta, PhD, PE, industry professor and director of biomedical engineering at Polytechnic Institute of NYU.
Conference participants from Downstate will include Eli A. Friedman, MD, distinguished teaching professor of medicine; William Urban, MD, chair of orthopedic surgery and rehabilitation medicine; Mark Stewart, MD, PhD, dean of the School of Graduate Studies; and Subrata Saha, PhD, research professor and director of musculoskeletal research in the Department of Orthopedic Surgery and Rehabilitation Medicine. Dr. Saha is also chair of the conference, which will launch a new publication – Ethics in Biology, Engineering & Medicine, An International Journal. Dr. Saha is editor-in-chief of the new publication.
In a welcoming letter, SUNY Chancellor Nancy L. Zimpher, PhD, said, “Biomedical engineering, a relatively new field among engineering disciplines, has already made significant contributions in the development of new medical devices, implants, and treatment modalities that have improved the quality of life for thousands of New Yorkers and beyond.” Sen. Kirsten E. Gillibrand wrote, “I commend all of the individuals participating in this weekend’s conference, and your efforts serve as an example of the positive contributions an individual can make to his or her profession, community and country.” In her welcoming letter, Rep. Yvette D. Clarke said, “As the federal representative for central Brooklyn, I am proud that this great borough will host such a critical meeting of the minds that will lead to great advancements in science and technology.”
More information is available at www.nyas.org/biomed.
###
About SUNY Downstate Health Sciences University
Downstate Health Sciences University in Brooklyn is one of four academic health centers (AMCs) in The State University of New York (SUNY) 64-campus system and the only SUNY AMC in New York City dedicated to health education, research, and patient care for the borough’s 2.7 million residents. Its flagship hospital, University Hospital at Downstate (UHD), is a teaching hospital and benefits from the expertise of Downstate’s exceptional medical school and world-class academic center research facilities. With a staff of over 800 physicians representing 53 specialties and subspecialties, Downstate offers comprehensive healthcare services to the community.
UHD provides high-risk neonatal and infant services, pediatric nephrology, and dialysis for kidney diseases and is the only kidney transplantation program in Brooklyn. Beyond its clinical expertise, Downstate houses a range of esteemed educational institutions, including its College of Medicine, College of Nursing, School of Health Professions, School of Graduate Studies, and School of Public Health. Downstate fosters innovation through its multifaceted biotechnology initiative, the Biotechnology Incubator and BioBAT, which support early-stage and more mature biotech companies.